"Placebos" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.
Descriptor ID |
D010919
|
MeSH Number(s) |
D26.660 E02.785
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Placebos".
Below are MeSH descriptors whose meaning is more specific than "Placebos".
This graph shows the total number of publications written about "Placebos" by people in this website by year, and whether "Placebos" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 0 | 1 | 1 |
1996 | 0 | 2 | 2 |
1997 | 0 | 1 | 1 |
1998 | 0 | 6 | 6 |
1999 | 1 | 5 | 6 |
2000 | 1 | 2 | 3 |
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 0 | 2 | 2 |
2004 | 1 | 2 | 3 |
2005 | 0 | 7 | 7 |
2006 | 0 | 5 | 5 |
2008 | 1 | 2 | 3 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 1 | 1 | 2 |
2013 | 1 | 2 | 3 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2016 | 0 | 4 | 4 |
2017 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2020 | 1 | 1 | 2 |
2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Placebos" by people in Profiles.
-
Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4400-e4413.
-
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial. Nat Med. 2021 05; 27(5):862-870.
-
Determinants of placebo effects. Int Rev Neurobiol. 2020; 153:27-47.
-
Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e206777.
-
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents. Sci Rep. 2018 11 19; 8(1):16970.
-
Single dose systemic acetaminophen to improve patient reported quality of recovery after ambulatory segmental mastectomy: A prospective, randomized, double-blinded, placebo controlled, clinical trial. Breast J. 2018 05; 24(3):240-244.
-
Comparison of trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscesses. CJEM. 2017 Jul; 19(4):308-311.
-
Differential CD4+ cell count increase and CD4+?: ?CD8+ ratio normalization with maraviroc compared with tenofovir. AIDS. 2016 08 24; 30(13):2091-7.
-
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. AIDS Res Hum Retroviruses. 2016 07; 32(7):636-47.
-
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Sci Transl Med. 2016 Jan 13; 8(321):321ra5.